BRUSSELS (dpa-AFX) - Thursday, Genmab A/S (GMAB) announced its financial results for the third quarter, reporting a net profit of $342 million, or $5.581 a share, compared with $401 million, or $6.46 a share, in the previous year.
Revenue increased to $1.187 billion from last year's $1.022 billion.
For the first nine months, the company reported revenue of $3.238 billion compared to $2.662 billion in 2025. Net profit stood at $698 million compared to $932 million. The decline in net profit was driven by higher costs and operating expenses.
Genmab expects its 2026 revenue to be in the range of $4.33 billion- 4.53 billion, driven by higher royalties, net product sales and collaboration revenue.
GMAB was trading at $53.89, down 2.23 percent on the Nasdaq.
Copyright(c) 2026 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2026 AFX News
